Results 101 to 110 of about 4,675 (154)

Endocannabinoid dynamics across marathon and ultramarathon running: evidence from two field studies. [PDF]

BMC Med
Siebers M, Huvermann D, Siebers C, Canales-Romero D, Florea-Ghile A, Keite L, John L, Munk M, Bizjak R, Witzel J, Schulz S, Kirsten J, Bindila L, Hinney A, Grau M, Bizjak DA, Engler H, Fuss J.   +17 more
europepmc   +1 more source

Luteolin as a dietary flavonoid for brain health: modulating neuroinflammation and cognitive decline in neurodegenerative disorders. [PDF]

Front Nutr
Jiang H, Pang X.
europepmc   +1 more source

Palmitoylethanolamide as an Intestinal Gatekeeper: Linking Inflammation, Angiogenesis and Colorectal Cancer Interception. [PDF]

Biomedicines
Palenca I, Sarnelli G, Esposito G.
europepmc   +1 more source

Orphan Nuclear Receptors expression and function in breast cancer cells: oncogenic action of the NR2F6 receptor. [PDF]

Cell Commun Signal
Caricasulo MA, Paroni G, Zanetti A, Brunelli L, Kurosaki M, Cavallaro AV, Foglia M, Remoli G, Guarrera L, Bolis M, Terao M, Garattini E.   +11 more
europepmc   +1 more source

Investigating Properties of Palmitoylethanolamide in Physiology and Disease: Far Beyond an Anti-Inflammatory Shield. [PDF]

Diseases
Veredice C, Turrini I, Pelanda H, Contaldo I, Rigante D.   +4 more
europepmc   +1 more source

Corrigendum to 'Effects of therapeutic interventions on long COVID: a meta-analysis of randomized controlled trials'. [PDF]

EClinicalMedicine
Tan C, Meng J, Dai X, He B, Liu P, Wu Y, Xiong Y, Yin H, Wang S, Gao S.   +9 more
europepmc   +1 more source

Editorial: Long- and post-COVID syndromes: immune mechanisms and therapeutic strategies. [PDF]

Front Immunol
Roncati L, Weissert R.
europepmc   +1 more source

Correction to "Palmitoylethanolamide Is a Disease-Modifying Agent in Peripheral Neuropathy: Pain Relief and Neuroprotection Share a PPAR-Alpha-Mediated Mechanism". [PDF]

Mediators Inflamm
europepmc   +1 more source

Effects of palmitoylethanolamide in clinical high-risk for psychosis: A nonrandomized open-label trial. [PDF]

Brain Behav Immun Health
Bortoletto R, Garzitto M, Basaldella M, Scipioni C, Sepulcri O, Fabris M, Curcio F, Balestrieri M, Colizzi M.   +8 more
europepmc   +1 more source

Palmitoylethanolamide (PEA) regulates cell cycle progression and promotes an anti-inflammatory transcriptomic signature in C2C12 skeletal muscle cells. [PDF]

Physiol Rep
Cole PL, Gillham SH, Viggars MR, Close GL, Owens DJ.   +4 more
europepmc   +1 more source